SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-143877
Filing Date
2015-04-23
Accepted
2015-04-23 14:26:40
Documents
8
Period of Report
2015-06-09
Effectiveness Date
2015-04-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A d912466ddef14a.htm DEF 14A 1120142
2 GRAPHIC g912466g29e21.jpg GRAPHIC 73318
3 GRAPHIC g912466g36p28.jpg GRAPHIC 5826
4 GRAPHIC g912466g61h58.jpg GRAPHIC 39533
5 GRAPHIC g912466g85g12.jpg GRAPHIC 67140
6 GRAPHIC g912466pc_pg1a.jpg GRAPHIC 6536
7 GRAPHIC g912466pc_pg1b.jpg GRAPHIC 1305
8 GRAPHIC g912466pc_pg2.jpg GRAPHIC 1339
  Complete submission text file 0001193125-15-143877.txt   1390853
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26727 | Film No.: 15788065
SIC: 2834 Pharmaceutical Preparations